Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

System Biosciences LLC pGreenZeo-mCMV Differentiation Reporter Negative ControlpGreenZeo-mCMV Plasmid (negative control) =10 µg
SDP

Catalog No. NC3500252
Encompass_Preferred

Run your pGreenZeo projects with confidence with the addition of this negative control that drives dscGFP and zeomycin resistance with a minimal CMV promoter. No need to make a negative control for your pGreenZeo projects—SBI’s already built one for you. The GreenZeo cassette is driven by a minimal CMV promoter with the dscGFP (destabilized copGFP, 2-hour half-life) and zeomycin marker co-expression mediated by a T2A element. This configuration provides a control for background levels of GFP and zeomycin expression in the absence of enhancer elements, such as the ones used in our Pluripotency Reporters.

Catalog No. NC3500252 Supplier System Biosciences LLC Supplier No. SR500PA1
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Run your pGreenZeo projects with confidence with the addition of this negative control that drives dscGFP and zeomycin resistance with a minimal CMV promoter. No need to make a negative control for your pGreenZeo projects—SBI’s already built one for you. The GreenZeo cassette is driven by a minimal CMV promoter with the dscGFP (destabilized copGFP, 2-hour half-life) and zeomycin marker co-expression mediated by a T2A element. This configuration provides a control for background levels of GFP and zeomycin expression in the absence of enhancer elements, such as the ones used in our Pluripotency Reporters.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.